<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39353979</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Assessing vaccinated persons' intention to take the COVID-19 boosters using a combined theoretical framework: an online survey in Egypt.</ArticleTitle><Pagination><StartPage>22795</StartPage><MedlinePgn>22795</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22795</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-72093-9</ELocationID><Abstract><AbstractText>Vaccines, like the Corona Virus Disease-2019 (COVID-19) vaccines, can control diseases, but vaccine hesitancy reduces their use. It is important to assess the intention to use COVID-19 vaccines boosters and the determinants of this intention to help in developing programs to promote the uptake of boosters. An online survey collected data from adults in Egypt between March and June 2022 using a questionnaire that assessed demographic characteristics, and constructs of the Theory of Planned Behaviour (TPB) and the Health Belief Model (HBM). The survey was uploaded to SurveyMonkey and the links were posted on social media platforms. Binary regression analysis was used and the dependent variable was intention to use boosters of COVID-19 vaccines. The independent variables were indicators of the HBM including perceived susceptibility to COVID-19 infection (medical history) and possibility of disease prevention (awareness of the availability of types of COVID-19 vaccines); and indicators of the TPB including attitude toward COVID-19 vaccines (that they are harmful, that they may lead to death and confidence in locally and foreign manufactured vaccines), perceived norms (the percentage of vaccinated persons in one's circle) and perceived control over booster uptake (presence of government mandates for COVID-19 vaccination). The confounders were sociodemographic factors (age, sex, education, and place of residence). Complete responses were available from 1113 out of 1401 participants (79.4%), with mean (SD) age = 25 (9.5) years, of whom, 66.7% (n = 742) were females and 68.6% (n = 764) were university students. About 39.4% and 31.2% indicated that they would get or would definitely get the booster dose of the COVID-19 vaccines. In multiple regression, intention to use a booster dose was significantly related to not agreeing (AOR = 4.87, P &lt; 0.001) or not agreeing at all (AOR = 8.46, P = 0.001) that vaccines are harmful and to having no confidence (AOR = 0.21, P &lt; 0.001) or no confidence at all (AOR = 0.14, P &lt; 0.001) in foreign-manufactured vaccines. Most university-educated Egyptians in the study intended to take the COVID-19 vaccine booster dose and this intention was associated with attitude toward the harm of the vaccine and confidence in foreign-manufactured vaccines. Awareness campaigns are needed to counteract misinformation and promote booster dose uptake.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El Tantawi</LastName><ForeName>Maha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Alexandria University, Champolion, Alexandria, Egypt. maha.tantawy@alexu.edu.eg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elwan</LastName><ForeName>Amira H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Alexandria University, Champolion, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Reham</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Endodontics, Faculty of Dentistry, The Egyptian Russian University, Badr City, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endodontics, Faculty of Dentistry, Minia University, Minia, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Nesreen Farouk</ForeName><Initials>NF</Initials><AffiliationInfo><Affiliation>Department of Public Health, Community, Environmental and Occupational Medicine, Faculty of Medicine Port Said University, Port Said, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elsheikh</LastName><ForeName>Enas I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Department of Public Health, Community, Environmental and Occupational Medicine, Faculty of Medicine Port Said University, Port Said, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hassan</LastName><ForeName>Heba Ali</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Pharmacognosy, Faculty of Pharmacy, Sohag University, Sohag, 82524, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Abdelwahab</LastName><ForeName>Sayed F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Medicine, Minia University, Minia, 61511, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004534" MajorTopicYN="N" Type="Geographic">Egypt</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033182" MajorTopicYN="Y">Intention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007117" MajorTopicYN="N">Immunization, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083342" MajorTopicYN="N">Health Belief Model</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088823" MajorTopicYN="N">Vaccination Hesitancy</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">Egypt</Keyword><Keyword MajorTopicYN="N">Health belief model</Keyword><Keyword MajorTopicYN="N">Theory of planned behaviour</Keyword><Keyword MajorTopicYN="N">Vaccination hesitancy</Keyword></KeywordList><CoiStatement>Maha El Tantawi is a Senior Board Member at BMC Oral Health. None of the other authors declare competing interests. The authors did not receive any external funds to support this research. 
<b>Ethical approval and consent to participate.</b>
 Ethical approval was obtained from the Research Ethics Committee, Faculty of Dentistry, Alexandria University, Egypt (0397–02/2022). The study was conducted in full accordance with the Helsinki declaration. Informed consent was obtained from all included participants.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39353979</ArticleId><ArticleId IdType="pmc">PMC11445433</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-72093-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-72093-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Haleem, A., Javaid, M. &amp; Vaishya, R. Effects of COVID-19 pandemic in daily life. Curr. Med. Res. Pract.10, 78–79. 10.1016/j.cmrp.2020.03.011 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147210</ArticleId><ArticleId IdType="pubmed">32292804</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. The impact of COVID-19 on global health goals. Accessed November 2, 2022 at: https://www.who.int/news-room/spotlight/the-impact-of-covid-19-on-global-health-goals (2021).</Citation></Reference><Reference><Citation>The College of Physicians of Philadelphia. Coronavirus | History of Vaccines. Accessed November 2, 2022 at https://historyofvaccines.org/diseases/coronavirus</Citation></Reference><Reference><Citation>Food and Drug Administration. FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine. Accessed November 2, 2022 at: https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19 (2020).</Citation></Reference><Reference><Citation>Food and Drug Administration. FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine. Accessed November 2, 2022 at: https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid (2020).</Citation></Reference><Reference><Citation>Marra, A. R. et al. The short-term effectiveness of coronavirus disease 2019 (COVID-19) vaccines among healthcare workers: A systematic literature review and meta-analysis. Antimicrob. Steward. Healthc. Epidemiol.10.1017/ASH.2021.195 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9495770</ArticleId><ArticleId IdType="pubmed">36168453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazy, R. M. et al. Acceptance of COVID-19 vaccine booster doses using the health belief model: A cross-sectional study in low-middle- and high-income countries of the east mediterranean region. Int. J. Environ. Res. Public Health19, 12136. 10.3390/IJERPH191912136 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9566578</ArticleId><ArticleId IdType="pubmed">36231447</ArticleId></ArticleIdList></Reference><Reference><Citation>Ipsos. Most adults vaccinated against COVID-19 in all 13 countries surveyed intend to get a booster shot. Accessed December 1, 2023 at: https://www.ipsos.com/en/global-attitudes-covid-19-vaccine-booster-shots (2021).</Citation></Reference><Reference><Citation>Al-Qerem, W. et al. Willingness of the Jordanian population to receive a COVID-19 booster dose: A cross-sectional study. Vaccines10.3390/VACCINES10030410 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8950968</ArticleId><ArticleId IdType="pubmed">35335042</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Qerem, W. et al. Knowledge, attitudes, and practices of adult Iraqi population towards COVID-19 booster dose: A cross-sectional study. Patient Prefer. Adherence16, 1525–1537. 10.2147/PPA.S370124 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9236163</ArticleId><ArticleId IdType="pubmed">35769339</ArticleId></ArticleIdList></Reference><Reference><Citation>Moeed, A. et al. Willingness and perceptions regarding COVID-19 vaccine booster dose in Pakistani vaccinated population: A cross-sectional survey. Front. public health.10.3389/FPUBH.2022.911518 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279681</ArticleId><ArticleId IdType="pubmed">35844859</ArticleId></ArticleIdList></Reference><Reference><Citation>Abouzid, M. et al. Attitudes toward receiving COVID-19 booster dose in the Middle East and North Africa (MENA) region: A cross-sectional study of 3041 fully vaccinated participants. Vaccines10, 1270. 10.3390/VACCINES10081270 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9414713</ArticleId><ArticleId IdType="pubmed">36016158</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, M. et al. Using an extended protection motivation theory to explain vaccine hesitancy: A cross-sectional study among Chinese adults. Human vaccin. immunother.10.1080/21645515.2022.2026136 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8993063</ArticleId><ArticleId IdType="pubmed">35103578</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, K. W. et al. COVID-19 vaccine hesitancy and its associated factors in Malaysia. PLoS ONE17, e0266925. 10.1371/journal.pone.0266925 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9436036</ArticleId><ArticleId IdType="pubmed">36048822</ArticleId></ArticleIdList></Reference><Reference><Citation>Romate, J. et al. Using the integrative model of behavioural prediction to understand COVID-19 vaccine hesitancy behaviour. Sci. Rep.10.1038/S41598-022-12466-0 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9166190</ArticleId><ArticleId IdType="pubmed">35661762</ArticleId></ArticleIdList></Reference><Reference><Citation>Short, M. B. et al. Understanding factors associated with intent to receive the COVID-19 vaccine. Fam. Syst. Health40, 160–170. 10.1037/FSH0000664 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35666894</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, M. et al. Behavioral intention and its predictors toward COVID-19 booster vaccination among Chinese parents: Applying two behavioral theories. Int. J. Environ. Res. Public Health10.3390/IJERPH19127520 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9224228</ArticleId><ArticleId IdType="pubmed">35742770</ArticleId></ArticleIdList></Reference><Reference><Citation>Barattucci, M. et al. Trust in science as a possible mediator between different antecedents and COVID-19 booster vaccination intention: An integration of health belief model (HBM) and theory of planned behavior (TPB). Vaccines10.3390/VACCINES10071099 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9320855</ArticleId><ArticleId IdType="pubmed">35891265</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Confirmed cases of COVID-19 in Egypt. Accessed December 1, 2023 at: https://covid19.who.int/region/emro/country/eg (2023).</Citation></Reference><Reference><Citation>Saied, A. A., Metwally, A. A., Madkhali, N. A. B., Haque, S. &amp; Dhama, K. Egypt’s COVID-19 recent happenings and perspectives: A mini-review. Front. Public Health9, 696082. 10.3389/fpubh.2021.696082 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415352</ArticleId><ArticleId IdType="pubmed">34485226</ArticleId></ArticleIdList></Reference><Reference><Citation>Our World in Data. Coronavirus Pandemic (COVID-19). Accessed November 2, 2022 at: https://ourworldindata.org/coronavirus (2020).</Citation></Reference><Reference><Citation>Dadras, O. et al. Public acceptability of COVID-19 vaccines and its predictors in Middle Eastern/North African (MENA) countries: A systematic review. Human Vaccin. Immunother.10.1080/21645515.2022.2043719 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9196809</ArticleId><ArticleId IdType="pubmed">35318872</ArticleId></ArticleIdList></Reference><Reference><Citation>Egypt Today. Egypt aims for cooperation with Cuba on vaccine production. Accessed November 2, 2022 at: https://www.egypttoday.com/Article/1/114996/Egypt-aims-for-cooperation-with-Cuba-on-vaccine-production (2022).</Citation></Reference><Reference><Citation>Elareed, H. et al. Public opinion towards COVID-19 vaccination in Egypt. Egypt. J. Community Med.41, 27–35. 10.21608/ejcm.2022.135572.1214 (2023).</Citation></Reference><Reference><Citation>Kandeel, A. et al. COVID-19 vaccination coverage in Egypt: a large-scale national survey—to help achieving vaccination target, March-May, 2022. BMC Public Health23, 397. 10.1186/s12889-023-15283-w (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9969364</ArticleId><ArticleId IdType="pubmed">36849954</ArticleId></ArticleIdList></Reference><Reference><Citation>Shawki, M. A. et al. COVID-19 vaccine hesitancy in Egypt: a cross-sectional study. J. Infect. Dev. Ctries.17, 1188–1198. 10.3855/jidc.17794 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37824346</ArticleId></ArticleIdList></Reference><Reference><Citation>Tharwat, S., Saad, A. M., Nassar, M. K. &amp; Nassar, D. K. Acceptance and hesitancy to receive COVID-19 vaccine among university students in Egypt: A nationwide survey. Trop. Med. Health51, 16. 10.1186/s41182-023-00509-9 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9995735</ArticleId><ArticleId IdType="pubmed">36895057</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuters. WHO declares end to COVID global health emergency. Accessed June 27, 2023 at: https://www.reuters.com/business/healthcare-pharmaceuticals/covid-is-no-longer-global-health-emergency-who-2023-05-05/ (2023).</Citation></Reference><Reference><Citation>Huang, P. C. et al. Expanding Protection Motivation Theory to explain vaccine uptake among United Kingdom and Taiwan populations. Hum. Vaccin. Immunother.19, 2211319. 10.1080/21645515.2023.2211319 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10294722</ArticleId><ArticleId IdType="pubmed">37212327</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, M. et al. COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study. Hum. Vaccin. Immunother.19, 2166323. 10.1080/21645515.2023.2166323 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10072063</ArticleId><ArticleId IdType="pubmed">36951564</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen, B. T., Labberton, A. S., Kour, P. &amp; Kraft, K. B. Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study. Hum. Vaccin. Immunother.19, 2188857. 10.1080/21645515.2023.2188857 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10072069</ArticleId><ArticleId IdType="pubmed">36941785</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin, C. et al. Assessing acceptability of the fourth dose against COVID-19 among Chinese adults: A population-based survey. Hum. Vaccin. Immunother.19, 2186108. 10.1080/21645515.2023.2186108 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10026929</ArticleId><ArticleId IdType="pubmed">36892289</ArticleId></ArticleIdList></Reference><Reference><Citation>Arab News. Egypt produces 30m doses of Vaccera-Sinovac vaccine. Accessed June 27, 2023 at: https://www.arabnews.com/node/2029116/middle-east (2023).</Citation></Reference><Reference><Citation>Lounis, M. et al. COVID-19 vaccine booster hesitancy (vbh) and its drivers in Algeria: National cross-sectional survey-based study. Vaccines.10.3390/VACCINES10040621 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9031698</ArticleId><ArticleId IdType="pubmed">35455371</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, D. T. et al. Willingness to receive COVID-19 vaccine booster doses for adults and their children in Vietnam. J. Hum. Behav. Soc. Environ.10.1080/10911359.2022.2046235 (2022).</Citation></Reference><Reference><Citation>COVID19 Vaccine Tracker. Egypt. Accessed November 2, 2022 at: https://covid19.trackvaccines.org/country/egypt/ (2022).</Citation></Reference><Reference><Citation>World Health Organization. WHODAS 2.0 TRANSLATION PACKAGE (VERSION 1.0) Accessed December 1, 2023 at: https://terrance.who.int/mediacentre/data/WHODAS/Guidelines/WHODAS%202.0%20Translation%20guidelines.pdf</Citation></Reference><Reference><Citation>Yusoff, M. S. B. ABC of content validation and content validity index calculation. Edu. Med. J.11, 49–54. 10.21315/eimj2019.11.2.6 (2019).</Citation></Reference><Reference><Citation>Wikipedia. List of Egypt's governorates. Accessed November 2, 2022 at: https://ar.wikipedia.org/wiki/قائمة_محافظات_مصر#المحافظات_حسب_الأقليم (2022).</Citation></Reference><Reference><Citation>TheGlobalEconomy.com. Egypt economic indicators. Accessed November 2, 2022 at: https://www.theglobaleconomy.com/Egypt/ (2022).</Citation></Reference><Reference><Citation>Data Reportal. DIGITAL 2022: EGYPT. Accessed December 1, 2023 at: https://datareportal.com/reports/digital-2022-egypt#:~:text=There%20were%2075.66%20million%20internet,percent)%20between%202021%20and%202022 (2022).</Citation></Reference><Reference><Citation>Larson, H. J., Jarrett, C., Eckersberger, E., Smith, D. M. D. &amp; Paterson, P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine32, 2150–2159. 10.1016/j.vaccine.2014.01.081 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24598724</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai, J. et al. The Influence of COVID-19 pandemic on physical health-psychological health, physical activity, and overall well-being: The mediating role of emotional regulation. Front. Psychol.12, 3005. 10.3389/FPSYG.2021.667461/BIBTEX (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415626</ArticleId><ArticleId IdType="pubmed">34484032</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens, G., Lodder, P., Smeets, T. &amp; Duijndam, S. Fear of COVID-19 predicts vaccination willingness 14 months later. J Anxiety Disord88, 102574. 10.1016/j.janxdis.2022.102574 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047433</ArticleId><ArticleId IdType="pubmed">35512598</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmoneim, S. A. et al. COVID-19 vaccine booster dose acceptance: Systematic review and meta-analysis. Trop. Med. Infect. Dis.10.3390/tropicalmed7100298 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9611447</ArticleId><ArticleId IdType="pubmed">36288039</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Interim statement on hybrid immunity and increasing population seroprevalence rates. Accessed November 2, 2022 at: https://www.who.int/news/item/01-06-2022-interim-statement-on-hybrid-immunity-and-increasing-population-seroprevalence-rates (2022).</Citation></Reference><Reference><Citation>Drew, L. Did COVID vaccine mandates work? What the data say. Nature607, 22–25. 10.1038/D41586-022-01827-4 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35794272</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills, M. C. &amp; Rüttenauer, T. The effect of mandatory COVID-19 certificates on vaccine uptake: Synthetic-control modelling of six countries. Lancet Public Health7, e15–e22. 10.1016/S2468-2667(21)00273-5 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8668192</ArticleId><ArticleId IdType="pubmed">34914925</ArticleId></ArticleIdList></Reference><Reference><Citation>Egypt Independent. Egypt enforces move to ban all unvaccinated citizens from government offices. Accessed November 9, 2022 at: https://egyptindependent.com/egypt-enforces-move-to-ban-all-unvaccinated-citizens-from-government-offices/ (2021).</Citation></Reference><Reference><Citation>Egypt Speeds Up Vaccination for University Students | Asharq AL-awsat.</Citation></Reference><Reference><Citation>Rahman, M. M. et al. Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh. PloS ONE17, e0270684 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9236250</ArticleId><ArticleId IdType="pubmed">35759475</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonmezer, M. C. et al. Knowledge, attitudes, and perception towards COVID-19 vaccination among the adult population: A cross-sectional study in Turkey. Vaccines10, 278. 10.3390/VACCINES10020278/S1 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8877322</ArticleId><ArticleId IdType="pubmed">35214736</ArticleId></ArticleIdList></Reference><Reference><Citation>Salem, G. M. et al. Acceptance rate of COVID-19 vaccination and its predictors in Egypt: An online survey. J. Infect. Dev. Ctries.16, 993–1000. 10.3855/JIDC.15603 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35797293</ArticleId></ArticleIdList></Reference><Reference><Citation>Barceló, J. et al. Vaccine nationalism among the public: A cross-country experimental evidence of own-country bias towards COVID-19 vaccination. Soc. Sci. Med.10.1016/J.SOCSCIMED.2022.115278 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9376148</ArticleId><ArticleId IdType="pubmed">35994879</ArticleId></ArticleIdList></Reference><Reference><Citation>The Cable News Network. Sinovac: Confidence in Chinese vaccines has taken a hit. But as coronavirus cases grow, some countries are still pushing ahead | CNN. Accessed November 2 2022 at: https://edition.cnn.com/2021/01/17/asia/sinovac-vaccine-asia-efficacy-intl-hnk/index.html (2021).</Citation></Reference><Reference><Citation>World Health Organization. WHO announces first technology recipients of mRNA vaccine hub with strong support from African and European partners. Accessed November 14, 2022 at: https://www.who.int/news/item/18-02-2022-who-announces-first-technology-recipients-of-mrna-vaccine-hub-with-strong-support-from-african-and-european-partners (2022).</Citation></Reference><Reference><Citation>Seddig, D. et al. Correlates of COVID-19 vaccination intentions: Attitudes, institutional trust, fear, conspiracy beliefs, and vaccine skepticism. Soc. Sci. Med.10.1016/J.SOCSCIMED.2022.114981 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9017059</ArticleId><ArticleId IdType="pubmed">35512613</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan, C. W. et al. Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study. Hum. Vaccin. Immunother.17, 3413–3420. 10.1080/21645515.2021.1933687 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437493</ArticleId><ArticleId IdType="pubmed">34170792</ArticleId></ArticleIdList></Reference><Reference><Citation>Asmare, G. et al. Behavioral intention and its predictors toward COVID-19 vaccination among people most at risk of exposure in Ethiopia: applying the theory of planned behavior model. Hum. Vaccin. Immunother.17, 4838–4845. 10.1080/21645515.2021.2011651 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903977</ArticleId><ArticleId IdType="pubmed">35213947</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain, F. et al. Intention to get COVID-19 vaccines: Exploring the role of attitudes, subjective norms, perceived behavioral control, belief in COVID-19 misinformation, and vaccine confidence in Northern India. Hum. Vaccin. Immunother.17, 3941–3953. 10.1080/21645515.2021.1967039 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828102</ArticleId><ArticleId IdType="pubmed">34546837</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah, I. et al. Factors affecting Pakistani young adults’ intentions to uptake COVID-19 vaccination: An extension of the theory of planned behavior. Brain Behav.10.1002/BRB3.2370 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613438</ArticleId><ArticleId IdType="pubmed">34543522</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi, Y. et al. Predicting intention to take a COVID-19 vaccine in the United States: Application and extension of theory of planned behavior. Am. J. Health Promot.36, 710–713. 10.1177/08901171211062584 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9014362</ArticleId><ArticleId IdType="pubmed">35041541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain, M. B. et al. Health belief model, theory of planned behavior, or psychological antecedents: What Predicts COVID-19 vaccine hesitancy better among the bangladeshi adults?. Front. Public Health10.3389/FPUBH.2021.711066 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8418098</ArticleId><ArticleId IdType="pubmed">34490193</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg, M. B. &amp; Lin, L. Predictors of COVID-19 vaccine intentions in the United States: The role of psychosocial health constructs and demographic factors. Transl. Behav. Med.11, 1782–1788. 10.1093/TBM/IBAB102 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8344533</ArticleId><ArticleId IdType="pubmed">34293163</ArticleId></ArticleIdList></Reference><Reference><Citation>Shmueli, L. Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model. BMC Public Health21, 804. 10.1186/S12889-021-10816-7 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075011</ArticleId><ArticleId IdType="pubmed">33902501</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidry, J. P. D. et al. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am. J. Infect. Control49, 137–142. 10.1016/J.AJIC.2020.11.018 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7677682</ArticleId><ArticleId IdType="pubmed">33227323</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>